Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Postoperative Delirium Prevention
NCT05849597Phase 3Recruiting
- Sponsor
- University of Novi Sad
- Start
- Mar 2022
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dexmedetomidine in delirium (2 arms), sponsored by University of Novi Sad. Primary endpoint: Occurrence of postoperative delirium at 5 days. Started Mar 2022; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT05849597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05849597.